project
influenza
vaccin
effectivenessmonitor
imov
part
european
research
carri
ecdc
european
center
diseas
prevent
control
aim
monitor
effect
vaccin
europ
grow
incid
flu
influenzalik
ill
come
epidem
season
laboratori
studi
use
molecular
rtpcr
biolog
method
detect
genet
materi
influenza
viru
respiratori
virus
perform
voivodeship
sanitaryepidemiolog
station
poland
valid
result
swab
taken
nose
throat
carri
depart
influenza
research
nation
influenza
center
warsaw
studi
involv
sampl
patient
across
poland
posit
result
record
sampl
influenza
viru
type
detect
type
b
case
wherea
case
respiratori
virus
detect
includ
human
parainfluenza
viru
type
human
respiratori
syncyti
viru
type
b
human
coronaviru
human
rhinoviru
type
b
c
human
enteroviru
human
adenoviru
result
show
although
influenza
virus
predomin
season
poland
flulik
virus
also
abound
great
number
influenza
case
record
epidem
season
although
vari
intens
vantam
sellwood
kissl
et
al
brydak
influenza
occur
everi
climat
latitud
central
europ
incid
influenza
influenzalik
ill
usual
start
increas
januari
march
globinska
kowalski
brydak
poland
number
case
influenza
influenzalik
ill
singl
season
vari
thousand
sever
million
globinska
kowalski
brydak
romanowska
brydak
record
case
talli
report
famili
doctor
frontlin
contact
patient
depend
number
case
report
epidemiolog
virolog
interpret
conduct
nation
scale
well
compar
evalu
global
scale
project
influenza
vaccin
effectivenessmonitor
imov
part
european
research
coordin
ecdc
primari
purpos
monitor
effect
influenza
vaccin
europ
growth
diseas
kissl
et
al
project
implement
countri
european
union
poland
join
program
first
time
epidem
season
prepar
manuscript
approv
institut
board
research
onestep
ace
detect
seegen
seoul
south
korea
methodolog
consist
determin
reaction
mixtur
specif
amplif
product
correspond
multipl
fragment
search
viru
genom
limit
side
sequenc
primer
use
pcr
order
estim
size
result
pcr
product
necessari
conduct
compar
analysi
pattern
size
dna
contain
fragment
variou
known
size
dna
read
perform
appli
amplicon
agaros
gel
carri
electrophoret
separ
swab
follow
inspect
document
result
geldoc
devic
quantiti
one
softwar
biorad
hercul
ca
obtain
reliabl
laboratori
result
virolog
test
depend
number
factor
depend
physician
collect
materi
includ
follow
type
materi
collect
time
sampl
collect
onset
diseas
storag
condit
materi
transport
laboratori
condit
time
transport
sampl
laboratori
failur
meet
specifi
requir
may
result
fals
neg
result
may
impact
patient
treatment
romanowska
brydak
optim
time
sampl
collect
within
day
symptom
strongest
materi
could
swab
nose
throat
nasopharyng
wash
aspir
nasopharynx
cerebrospin
fluid
sampl
taken
patient
sent
laboratori
includ
inform
patient
age
gender
influenza
vaccin
antivir
medicin
taken
onset
symptom
date
materi
collect
sampl
obtain
physician
particip
imov
project
detect
respiratori
viral
genet
materi
success
case
pathogen
respons
respiratori
tract
infect
addit
bacteria
virus
fungi
parasit
figur
present
percentag
virus
detect
clinic
specimen
result
show
influenza
respiratori
virus
major
clinic
virolog
epidemiolog
problem
sampl
epidem
season
imov
project
presenc
genet
materi
influenza
viru
type
b
detect
case
repres
sampl
investig
share
held
influenza
viru
type
shown
fig
remain
posit
sampl
ie
follow
respiratori
virus
detect
human
parainfluenza
viru
type
human
respiratori
syncytia
viru
type
b
human
coronaviru
human
rhinoviru
type
b
c
human
enteroviru
human
adenoviru
case
coinfect
two
respiratori
virus
report
constitut
seriou
clinic
problem
lack
suitabl
effect
antivir
drug
neuraminidas
inhibitor
oseltamivir
zanamivir
suitabl
influenza
treatment
drug
effect
prevent
infect
caus
virus
respiratori
system
arrang
coinfect
viral
pair
detect
present
tabl
outbreak
influenza
influenzalik
virus
occur
everi
epidem
season
cover
world
popul
brydak
mani
year
medicin
use
molecular
biolog
method
rapid
viral
diagnosi
benefici
individu
patient
also
result
econom
benefit
countri
vantam
sellwood
costeffect
way
combat
influenza
prevent
vaccin
virus
infect
epitheli
cell
respiratori
tract
caus
divers
defens
respons
organ
tri
differ
way
avoid
immun
mechan
aim
elimin
infecti
agent
globinska
kowalski
understand
way
virus
avoid
bodi
antivir
respons
may
serv
tool
develop
new
method
treatment
respiratori
diseas
integr
epidemiolog
virolog
influenza
surveil
system
conduct
poland
well
intern
project
imov
significantli
contribut
evalu
spread
influenza
respiratori
virus
popul
investig
program
also
allow
assess
compar
epidemiolog
virolog
situat
differ
countri
result
greater
awar
vaccin
influenza
